Peroxiredoxin VI (Prdx6) is a dual-functioning antioxidant enzyme that acts to protect biological membranes against damage caused by lipid peroxidation [1, 2] . The enzyme displays glutathione peroxidase [3] and calcium-independent PLA 2 [4, 5] activities with specificity for phospholipid hydroperoxides providing physiological protection after cell exposure to oxidative stress. The glutathione peroxidase activity of Prdx6 is regulated by initial heterodimerization with, and subsequent S-glutathionylation by, glutathione-loaded glutathione S-transferase Pi (GSTP) [3, 6, 7] . One distinctive function of GSTP is its ability to form a redox complex with a target protein with subsequent delivery of bound and activated glutathione (thiolate anion) for S-glutathionylation of target proteins [8] . In the case of Prdx6, the catalytic Cys47 is buried in the hydrophobic globular core region of the protein. After reduction of peroxides, this cysteine becomes oxidized to a sulfenate and GSTP participates in overcoming the accessibility barrier for glutathione (GSH) to reach this hydrophobic region and reactivate Prdx6.
GSH S-transferases are multifunctional isoenzymes that can detoxify xenobiotics and endogenous metabolites primarily by catalyzing their conjugation with GSH [9, 10] . GSTP1-1 is overexpressed in tumors and in cell lines selected for resistance to certain anticancer agents and has been shown to be polymorphic [11] , a characteristic that imbues potential selective catalytic properties on the individual isozymes. The genetic polymorphisms in the GSTP1 gene arise from nucleotide transitions that change codon 105 from Ile to Val and codon 114 from Ala to Val, generating four GSTP1 alleles: wild-type GSTP1-1A (Ile105/ Ala114), GSTP1-1B (Val105/Ala114), GSTP1-1C (Val105/Val114), and GSTP1-1D (Ile105/Val114) [12, 13] . The Ile105-Val105 and Ala114-Val114 substitutions do not alter glutathione-binding affinity, but cause a steric change at the substrate-binding site of the enzyme [13, 14] . The GSTP variants have different catalytic rates for the formation of thioether conjugates between GSH and some small-molecule electrophiles [12, 14] . Altered conformation of the substrate-binding site(s) may contribute to final substrate specificity. The hydrophobicity and size of residue 114 could serve as an important determinant of the substrate specificity of each of the GSTP1 isozymes [15] . On the other hand, because GSTP1-1D, bearing Ile105 and Val114, has enzyme activity toward CDNB Q2 comparable to that of GSTP1-1A, Val105 may circumvent the influence of Val114 [13] . There are some examples in which distinct polymorphisms influence response to specific anticancer drugs. For example, GSTP1-1A has a role in the acquisition of cisplatin resistance reportedly through enhancing the formation of platinum-glutathione conjugates [16] . There are also some indications of epidemiological correlations for GSTP isotype expression with etiological aspects of endometrial [17] , bladder, and testicular cancers [18] . In this report we sought to determine if polymorphic variants of GSTP1 have a general impact on the response to oxidative stress by directly influencing the peroxidase functions of Prdx6.
Materials and methods

Reagents
Phosphate-buffered saline (PBS; pH 7.4; Invitrogen, Carlsbad, CA, USA), RPMI 1640 (Mediatech, Manassas, VA, USA), fetal bovine serum (FBS; Atlas Biologicals, Fort Collins, CO, USA), DPPP (diphenyl-1-pyrenylphosphine; Dojindo, Japan), glutathione (reduced) and glutathione (oxidized) (Sigma-Aldrich), glutathione reductase (GR; from baker's yeast; Sigma), b-nicotinamide adenine dinucleotide phosphate reduced tetrasodium salt (NAD(P)H; Sigma), 1-hexadecyl-3-(trifluoroethyl)-sn-glycero-2-phosphomethanol lithium (MJ33; Sigma), ethylene glycol-bis(2-aminoethylether)-N,zN,N 0 ,N 0 -tetraacetic acid, 3,3 0 ,3 00 -phosphanetriyltripropanoic acid (TCEP), ascorbic acid (sodium salt; ASC), and CuSO 4 and 3-amino 1,2,4-triazole (all from Sigma) were used. Purified Escherichia coli-expressed Prdx6 (495% purity) was from ProSpec-Tany TechnoGene (Ness Ziona, Israel). Alexa 546 N-succinimidyl ester and QSY 35 acetic acid, succinimidyl ester, were from Invitrogen.
Tissue culture
MCF-7 cells were purchased from the ATCC (Manassas, VA, USA) and were cultured in RPMI 1640 medium with 10% FBS in a humidified incubator at 37 1C in an atmosphere of 5% CO 2 . The rationale for using MCF-7 cells for our studies is that the GSTP gene is transcriptionally silenced; therefore the levels of GSTP are essentially undetectable.
Expression of GSTP1-1 allelic variants in MCF-7 cells
Exponentially growing MCF-7 cells were transfected using GenJet (in vitro DNA transfection reagent for MCF-7 cells (version II); SignaGen Laboratories, Rockville, MD, USA) with pCMV-Tag2a-Flag (Kan R and Neo R ) empty or GSTP1-1A-encoding vectors. The transfection efficiency was $ 60% as detected from green fluorescent protein expression and flow-cytometric analysis. The sitedirected mutagenesis of the GSTP1-1A vector was performed using the primers (Integrated DNA Technologies, Coralville, IA,
0 -ACACCAACTATGAGGTGGGCAAGGATGAC-3 0 (Ala114Val), and 5
0 -ACCATCCTGCGTCACCT-3 0 (Tyr7Phe) for PCR amplification and the QuikChange multisite-directed mutagenesis kit (Stratagene, La Jolla, CA, USA) according to the manufacturer's recommendations.
E. coli expression and purification of wild-type and allelic variants of GSTP1-1
His-tagged GSTP1-1A (WT), the inactive Y7F mutant, and GSTP1-1B, -1C, and -1D were expressed in E. coli and purified up to $85% of homogeneity with Ni-column ion-exchange chromatography [12, 19] .
Immunoblot detection of GSTP1-1 allelic variants, GSTM, PHGPx (GPx4), and Prdx6 in MCF-7 cell lysates SDS-PAGE was performed using 12% Tris-Glycine 1.5 mM/15-well precast gels, XCell SureLock electrophoresis cells, and Novex protein analysis solutions (all from Invitrogen). Electrophoretically resolved proteins were transferred onto polyvinylidene difluoride membranes (Bio-Rad, Hercules, CA, USA). Nonspecific binding was blocked by incubating membranes in Tris-buffered saline with 0.1% Tween 20 containing 5% dry nonfat milk or 5% bovine serum albumin Fraction V. Specific polyclonal rabbit antiPrdx6 (1:4000 dilution; Strategic Biosolutions, Ramona, CA, USA), polyclonal rabbit anti-GSTM5 (1:1000 dilution; Abnova, Walnut, CA, USA), polyclonal rabbit anti-GPx4 (1:500 dilution; Cayman Chemical, Ann Arbor, MI, USA), mouse monoclonal anti-GAPDH (1:2000 dilution; Abcam, Cambridge, MA, USA), and anti-GSTP1 (1:500 dilution; MBL International, Woburn, MA, USA) antibodies were incubated with membranes for 2 h at room temperature or overnight at 4 1C. After the membranes were washed with PBS (three times) they were incubated with secondary horseradish peroxidase (HRP)-conjugated or green (or red) chromophoreconjugated antibodies (Li-Cor Biosciences, Lincoln, NE, USA) for 1 to 2 h at room temperature. The blots with HRP-conjugated secondary antibodies were developed with enhanced chemiluminescence (GE Healthcare Bio-Sciences Corp.). Recombinant purified human Prdx6 (ProSpec-Tany TechnoGene) and GSTP1-1 were used as standards. The blots were scanned, visualized, and quantified with a ChemiDoc system (Bio-Rad) using Quantity One 2-D analysis software (Bio-Rad). The blots with green (and red) fluorescent secondary antibodies were imaged and quantified with the dual-color IR-excited fluorescence imager Odyssey CLx using Image Studio 1.0.9 software (all from Li-Cor).
Quantification of relative amounts of Prdx6, GSTP1, GSTM, and GPx4 SDS-PAGE of control and transfected MCF-7 cells was performed under reducing conditions (4 mM TCEP in the loading buffer). Proteins were electrophoretically resolved, transferred to membranes, and subjected to immunodetection with appropriate primary and fluorescently labeled secondary antibodies. The blots with simultaneous detection of GAPDH (red fluorescence, monoclonal antibody) and Prdx6 (or GPx4, GSTP1, GSTM) (green fluorescence, polyclonal antibody) were visualized on an Odyssey CLx imager and quantified using Image Studio 1.0.9 software. Relative amounts of the GSTP1 allelic variants, GSTM, Prdx6, and GPx4 were calculated after normalization with GAPDH. Quantitative results are presented as means7SE for three independent experiments in Fig. 2 .
Fluorescence analysis of Prdx6 peroxidase activity
We used a standard GSH reductase/GSH/NADPH-coupled assay [1] lysates were used instead of purified proteins for analysis of peroxidase activity under similar conditions. PLPCOOH was freshly prepared using a lipoxygenase-mediated oxidation of PLPC (Sigma) with purification using C 18 Sep-Pack microcolumns (Waters, Milford, MA, USA) [1] . To show specificity of Prdx6 peroxidase activity we used a specific competitive Prdx6 inhibitor, MJ33 [4] . To exclude any (essentially trivial) catalasemediated H 2 O 2 degradation (in experiments with H 2 O 2 as a substrate) in cell lysates we preincubated our samples with 3-amino-1,2,4-triazole (250 mM; 3-AT; Sigma).
The peroxidase activities of Prdx6/GSTP1-1 in vitro and in MCF-7 cell lysates are presented in Table 1 as means7SD for three independent experiments.
Prdx6 binding to GSTP1-1
Purified Prdx6 protein was incubated with fivefold excess of succinimidyl ester of Alexa 546 Fluor (Alexa546) carboxylic acid (Invitrogen), and GSTP1-1 allelic variant purified proteins were incubated with fivefold excess of succinimidyl ester of QSY 35 (QSY35) acetic acid (Invitrogen) in 0.1 M sodium bicarbonate, pH 8.3, at room temperature, overnight, under constant agitation to label primary amines. The reaction mixture was processed using a BioSpin 6 (Bio-Rad) size-exclusion spin microcolumn to remove excess unreacted dyes and exchange reaction buffers to 10 mM PB Q3 (pH 7.4). Spectroscopic analysis of Alexa546 or QSY35 label incorporation showed $ 2.0 mol of each dye per mole of Prdx6 or GSTP1-1 allelic variant monomer, respectively.
All labeled allelic variants were preincubated with 1 mM GSH before any titration experiments.
The fluorescence analysis of the FRET-based (R 0 ¼25Å for Alexa546/QSY35 couple) protein binding was performed using the QM-4 spectrofluorimeter (PTI). The titrations of Prdx6 and GSTP1-1 were performed using 2.0 nM Alexa546-labeled Prdx6 and the indicated concentrations of the QSY35-labeled GSTP1-1 proteins in a 10 Â 10 Â 40-mm quartz cuvette in a fluorimeter sample holder under constant stirring at room temperature. The emission spectra of Alexa546-labeled Prdx6 were recorded and integrated (ex 546 nm) before any titration experiment. The indicated amounts of QSY35-labeled GSTP1-1 allelic variants were added to Alexa546-labeled Prdx6 in solution. After incubation for 5 min, emission spectra of Alexa546 were recorded. The integral of these was subtracted from the initial Alexa546 spectra and the results were normalized for the integral of the initial spectra. The y axis represents the decrease in Alexa546 emission, which is proportional to those amounts of GSTP1-QSY35 bound to Prdx6. The x axis represents the total amount of added labeled GSTP1-1. Experimental data were analyzed using standard SigmaPlot pharmacological applications (''One binding site with saturation'' model, version 10.0; Systat Software, San Jose, CA, USA) and fit with the hyperbolic equation
where X is the concentration of total GSTP1-1 allelic variant labeled with QSY35, Y represents the amount of GSTP1-1 allelic variant bound to Alexa546-labeled Prdx6, K D is the apparent equilibrium dissociation constant, and B max is the maximal number of high-affinity binding sites on Prdx6 for each GSTP1-1 allelic variant.
To show the effects of Prdx6 fluorescent labeling on the specificity of its binding to GSTP1-1 competition experiments were performed. At each point of Prdx6-Alexa546 (2.0 nM) titration the emission spectra of Alexa546 were recorded before and after 5 min incubation with the indicated amount of GSTP1-1-QSY35 . After that   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65  66   67  68  69  70  71  72  73  74  75  76  77  78  79  80  81  82  83  84  85  86  87  88  89  90  91  92  93  94  95  96  97  98  99  100  101  102  103  104  105  106  107  108  109  110  111  112  113  114  115  116  117  118  119  120  121  122  123  124  125  126  127  128  129  130  131 132 the same amount (2.0 nM) of intact unlabeled Prdx6 was added and after 5 min of incubation (room temperature), the emission spectra of Alexa546 were recorded. In parallel experiments Prdx6-Alexa546 (2.0 nM) was incubated with unlabeled protein (2.0 nM) and emission spectra were recorded. Both emission spectra were integrated and used for normalization of the effect of GSTP1-1-QSY35 addition according to the formula
where R INT corresponds to the integration of the labeled Prdx6 or of the labeled Prdx6 after incubation with intact protein emission spectra and R GSTP1-1 corresponds to the integration of the emission spectra after GSTP1-1-QSY35 addition to labeled protein or to dilution of the Prdx6-GSTP1-1 complex with intact Prdx6. All spectra were corrected for trivial dilution effect. Our results indicate greater than two times decreased binding of GSTP1-1 to labeled Prdx6 in the presence of an equal amount of intact Prdx6 (not shown). To show the effects of GSTP1-1 allelic variant fluorescent labeling on the specificity of its binding to Prdx6 we used a ''back titration'' method with intact unlabeled proteins. The methodology of both controls is described in great detail in our recent publication [20] . Our results show minimal effect of fluorescent labeling on the affinity of GSTP1-1 binding with Prdx6.
To show competition between allelic variants of GSTP1-1 for the same binding sites on Prdx6 we preincubated 2.0 nM labeled Prdx6 with 250 nM intact unlabeled GSTP1-1A (saturating concentration) for 5 min and then titrated with the indicated amounts of each of the other allelic variants, GSTP1-1B, GSTP1-1C, or GSTP1-1D, labeled with QSY35. The emission spectrum of Alexa546 after each addition of labeled allelic variant was recorded, integrated, subtracted from the spectrum before titration, and normalized for the spectral integration of the latter. To account for the role of GSH on Prdx6-GSTP1 binding, titration of Alexa546-labeled Prdx6 with QSY35-labeled GSTP1-1A without preincubation with GSH was performed.
The final results of B max and K D are presented in Table 2 as means7SD for five independent experiments.
Fluorescence detection of lipid peroxidation in MCF-7 cells
Intact MCF-7 cells were grown to $70% confluence attached to 12 Â 25-mm plastic slides (Aclar; Electron Microscopy Sciences, Hatfield, PA, USA) in RPMI 1640 medium (with 10% FBS) in a humidified incubator at 37 1C in an atmosphere with 5% CO 2 . These cells were transfected with empty vector, Y7F mutant of GSTP1-1A, GSTP1-1A, GSTP1-1B, GSTP1-1C, or GSTP1-1D using procedures described above and harvested at 490% confluence. The transfection efficiency was $60%. The slides with control and transfected cells were labeled with DPPP (5 mM final concentration, 45 min at 37 1C) in complete medium, washed three times with PBS (pH 7.4), and placed in a quartz cuvette (10 Â 10 mm, on diagonal) with 3 ml of PBS (pH 7.4). The DPPP emission (ex 352 nm, em 380 nm) was recorded $ 1 min before and $10 min after an addition of 0.2 mM ascorbic acid (sodium salt, pH 7.4) and 10 mM CuSO 4 (to generate OH d outside the cells [1] ) in an SM-4 fluorimeter (PTI) at 37 1C under constant gentle stirring in real-time kinetics. After each kinetic experiment the cells were placed in a petri dish with fresh medium for 36 h and then detached from the slide with trypsin, and their viability was determined using trypan blue exclusion and counting in a Cellometer Auto T4 (Nexcelom; Biosciences, Lawrence, MA, USA).
Similar cells and treatments were used for the imaging of DPPP fluorescence with a Radiance 2000 confocal microscope (Bio-Rad). The fluorescence and CIT
Q4
images of particular cells on slides (with similar DPPP labeling) were acquired before and $10 min after ascorbic acid-Cu 2 þ addition and processed using standard confocal microscope software. The traces of DPPP emission kinetics and the corresponding images are representative of three independent experiments.
Statistical treatment of experimental data
Experimental data were processed using SigmaStat 10.0 (Systat, Chicago, IL, USA) standard software and where relevant are presented as means7SD for the number of independent experiments indicated. Statistical relevance of differences was determined using ANOVA.
Results
Unlike most tumor cell lines, MCF-7 cells have intrinsically low expression levels of GSTP1-1 [3] . Prdx6 expression in these cells was measureable and was unaffected by forced expression of various GSTP1-1 allelic variants (Figs. 1A, 2C , and 2D). Our data confirm both barely detectable levels of GSTP1 and appropriate expression levels of GSTP1-1 after selection of pertinent clones of transfectants (WT transfected with empty vector (V), Y7F mutant, and allelic variants; Figs. 1B, 2A, and 2B). GSTM was detected in MCF-7 cells, but was unaffected by expression of GSTP1-1 allelic variants (Fig. 2B) . In contrast, levels of PhGPx (GPx4) expression were decreased by expression of GSTP1-1 allelic variants (Fig. 2D) . The redox state of Prdx6 is regulated through its heterodimerization with GSTP1, which serves to deliver activated GSH (GS À ) as a source of electrons for reduction of its catalytic cysteine sulfenate. Consequently, disulfide-based homo/heterodimerization of Prdx6 correlates with protein reduction (activation). We used TCEP to reduce the disulfide of Prdx6 homo/heterodimerization (Fig. 1A , lower and upper arrows, respectively). Quantification of Prdx6 monomer/dimer patterns (from Fig. 1A ) was influenced by the GSTP1-1 variant expression. For example, either GSTP1-1A or GSTP1-1C was more effective at forming the heterodimer with Prdx6 than either GSTP1-1B or GSTP1-1D (Figs. 1C and 1D ). This would be expected to result in better reduction (activation) of Prdx6 by either GSTP1-1A or GSTP1-1C. Expression and purification of His-tagged GSTP variants in E. coli provided a source of essentially homogeneous proteins, which were used for subsequent in vitro experiments (Fig. 1E) .
GSTP1-1 catalyzed reduction of Prdx6 enhances its peroxidase activity. Using standard NADPH/GR/GSH-coupled assays we used cell lysates from the transiently transfected cells to measure the influence of GSTP1 allelic variation on peroxidase activity. Specificity for detection of Prdx6 activity was provided by selection of PLPCOOH as a substrate. The catalytically inactive purified Y7F   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64Table 2 Binding parameters of GSTP1-1 allelic variants to Prdx6. 
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mutant of GSTP1-1A was the negative control and did not facilitate PLPCOOH reduction (Fig. 3A) . For the variants, the hierarchy for reduction of PLPCOOH was GSTP1-1A4GSTP1-1C4GSTP1-1B4GSTP1-1D (all were preloaded with GSH for all in vitro experiments). When PLPCOOH was used as a substrate, preincubation of the cell lysates (or in vitro proteins) with MJ33
(a PLPCOOH binding to Prdx6 inhibitor at 100 mM) abolished peroxidase activity (Table 1) . For general Prdx6-mediated peroxidase activity H 2 O 2 was also used as a substrate (Fig. 3B) . To eliminate the possible effects of catalase, cell lysates were preincubated with 100 mM 3-AT. Our results mirrored those for PLPCOOH: GSTP1-1A4GSTP1-1C4GSTP1-1B4GSTP1-1D (with no activity for GSTP1-1A Y7F mutant). Of note, the addition of MJ33 as a specific Prdx6 inhibitor influenced only the reduction of PLPCOOH and not H 2 O 2 . All data for peroxidase activities of Prdx6 for the cell lysates and in vitro experiments are summarized in Table 1 .
For quantification of plasma membrane-associated lipid peroxidation, MCF-7 cells transfected with GSTP1-1 allelic variants were labeled with DPPP, which specifically accumulates in the lipid bilayers of plasma membranes and becomes fluorescent after oxidation by lipid hydroperoxides [1] . After extracellular chemical generation of
kinetic analyses (Fig. 4A) showed that expression of GSTP1-1A and GSTP1-1C quantitatively suppressed lipid peroxidation in the plasma membranes of MCF-7 cells, whereas expression of the Y7F mutant of GSTP1-1A, GSTP1-1B, and GSTP1-1D showed a rapid ( $ 300 s) accumulation of lipid hydroperoxides. In addition, 36 h incubation of MCF-7 cells transfected with GSTP1-1 allelic variants after d OH exposure in fresh medium compromised the viability of cells transfected with GSTP1-1B, GSTP1-1D, and the Y7F mutant of GSTP1-1A compared to cells transfected with GSTP1-1A or GSTP1-1C (Fig. 4B) .
Confocal imaging of WT and transiently transfected MCF-7 cells (labeled with DPPP) showed substantial DPPP-associated fluorescence localized primarily (10 min after Cu 2 þ -ASC addition) in plasma membranes of GSTP1-1B-, GSTP1-1D-, and Y7F mutant of GSTP1-1-expressing cells (Fig. 5) . Consistent with the kinetic results (Fig. 4A ) only minimal DPPP fluorescence was detected in the plasma membranes of GSTP1-1A-and GSTP1-1C-transfected cells (Fig. 5) . Activation of Prdx6 by heterodimerization with GSTP requires effective binding interactions of the participating proteins. To determine the affinity of binding for the proteins forming the heterodimer, purified recombinant Prdx6 and GSTP1-1 (A, B, C, D, or Y7F mutant) were used for fluorescent labeling and FRET-based analyses. Our data showed similar high affinities of GSTP1-1A and GSTP1-1C for Prdx6 (Fig. 6, Table 2 ). Binding affinities for GSTP1-1B and GSTP1-1D for Prdx6 were statistically significantly lower (Fig. 6C) . Fig. 6D presents actual volume (amino acids 105 and 114) changes in the vicinity of the allelic variant GSTP1-1 close contact site with Prdx6 (Fig. 7) . Our data show small changes for GST1-1C compared to those for GSTP1-1B or GSTP1-1D. Preincubation of Prdx6 with GSTP1-1A before titration with GSTP1-1B (or GSTP1-1C or GSTP1-1D) indicated essentially the same binding sites for each of the GTTP1-1 allelic variants. Only maximal numbers of binding sites (B max ) and not binding affinities (K D ) were altered. The absence of GSH in the binding mixture 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63 64 Fig. 3 . Peroxidase activity of Prdx6 in MCF-7 cell lysates and in vitro. (A) NADPH fluorescence traces for MCF-7 cell lysates ( $ 50 mg of total protein) transiently expressing GSTP1-1 allelic variants (Cell GSTP1-1A (or GSTP1-1B, GSTP1-1C, GSTP1-1D)) or for in vitro analysis using recombinant Prdx6 (ProSpec-Tany TechnoGene, 2.5 mg) and GSTP1-1 E. coli-expressed and purified proteins (GSTP1-1A, GSTP1-1B, GSTP1-1C, GSTP1-1D) and catalytically inactive mutant Y7F of GSTP1-1A, 2.5 mg, respectively, after 50 mM PLPCOOH addition (arrow). 
Y. Manevich et al. / Free Radical Biology and Medicine ] (]]]]) ]]]-]]]
produced extensive decreases in binding affinity values, indicating that GSH loading of GSTP1-1 plays a crucial role in stabilizing the Prdx6-GSTP1 complex ( Table 2 ).
Discussion
Regulation of redox homeostasis is critical in the maintenance of normal cell functions, and both glutathione S-transferase and peroxiredoxin enzymes are important contributors to this process. There are numerous reports of aberrant expression patterns of GSTP linked with cancer and with altered response of tumor cells to a variety of anticancer drugs (reviewed in [21] ). The identification of single-nucleotide polymorphisms in GSTP1-1 (Ile/Val105, Ala/Val114) has led to attempts to correlate their incidence with disease susceptibility and drug metabolism. For example, the GSTP1-1B allele was found to associate with bladder and testicular cancer, and decreased GSTP1-1A was linked with prostate cancer, but associations between GSTP1-1 polymorphisms and colorectal or lung cancer have not been found [18, 22] . In a similar vein, increased expression of Prdx6 has been associated with malignancies of various organ sites including breast [23] , and Prdx6 supports the growth, invasiveness, and metastasis of breast cancer cells [24] . Moreover, the general peroxidase and PLA 2 activities of Prdx6 promote growth and metastases of cancer cells [25, 26] . Although epidemiological studies remain inconsistent, based on the protein interactions that regulate responses to reactive oxygen species, activation of Prdx6 as a peroxidase initially depends on its heterodimerization with GSTP1-1 [2,3,6 ]. S-glutathionylation of target proteins is a function recently ascribed to GSTP1-1 [27] and Prdx6 is one of the enzymes for which S-glutathionylation serves to enhance enzyme activity [8] .
The in silico modeling (Fig. 7) and deletion studies suggest that the sites of closest contact between Prdx6 and the GSTP1-1 monomers are on the interface of their interaction at residues 115-124 for GSTP1-1 and 163-169 for Prdx6 [6] . Adding a GSTP1-1 synthetic peptide (aa 113-130) into the mixture of Prdx6 and GSTP1-1 results in a substantial inhibition of heterodimerization of these proteins ($ 80%) [6] . Amino acid 114 (Ala for GSTP1-1A or GSTP1-1B or Val for GSTP1-1C or GSTP1-1D) is in this site of interaction and could be critical in stabilizing the complex. Another GSTP1-1 synthetic peptide (aa 98-112) also inhibits GSTP1-1 and Prdx6 heterodimerization by$25% [6] . This site contains amino acid 105 (Ile in GSTP1-1A and GSTP1-1D or Val in GSTP1-1B and GSTP1-1C), which also influences protein binding [6] . Such observations imply that each site of the GSTP1-1 allelic variation (aa 105 and 114) may be involved in its binding to Prdx6. Most probably, the combination of differences in molecular volume (Ala, 69Å ) and hydrophobicity in the side chains will influence the affinity of GSTP1-1 for Prdx6. Our present data show that affinities of GSTP1-1A (K D 51 nM) or GSTP1-1C (K D 57 nM) for Prdx6 are higher than those of GSTP1-1B (K D 101 nM) or GSTP1-1D (K D 94 nM). The affinity of binding determines proximity between a catalytic Cys47-sulfenate of Prdx6 and activated GSH (thiolate) bound to the GSTP1-1 allelic variant and, consequently, the efficiency with which the sulfenate at Cys47 is S-glutathionylated and reduced (i.e., activated) [6] . Our data show that the peroxidase activities of MCF-7 cell lysates transiently transfected with GSTP1-1A or GSTP1-1C were substantially higher than those of the same cells transfected with either GSTP1-1B or GSTP1-1D. The catalytically inactive Y7F mutant of GSTP1-1A did not   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64 support activation of Prdx6 (Table 1 ) and furthermore peroxidase activity toward phospholipid hydroperoxide was abolished by the addition of specific Prdx6 inhibitor MJ33 [6] . The interface of the Prdx6-GSTP1-1 heterodimer is essentially similar to that of the GSTP1-1 homodimer (Fig. 7) . E. coliexpressed and purified GSTP1-1A has better catalytic efficiency and greater affinity for CDNB (K m ¼0.3370.07 mM) than GSTP1-1B (K m ¼1.1570.07 mM) [28] . Because the active unit of GSTP1-1 is a homodimer [6] , this result may be explained by differences in interactions between monomeric subunits, similar to those for the Prdx6-GSTP1-1 heterodimer shown here. As a further corollary, in earlier studies the bulkiness of aa 105 (Ile/Ala, Ile/Val, Ile, and Ile/Trp) was shown to correlate negatively with GSTP1-1 k cat /K m values for anti-diol epoxides [29] .
Thus, our data demonstrate that polymorphisms of GSTP1-1 differentially mediate activation of Prdx6 peroxidase activity, providing a platform to imply that contingent upon their GSTP genotype, individuals will have significant differences in mounting an antioxidant response, particularly affecting protection of cell membranes against lipid peroxidation. Of particular interest, our results indicate that quantitative GSTP1-1 expression inversely correlates with GPx4 levels in MCF-7 cells. This could indicate the presence of a coregulatory mechanism governing expression of Prdx6 and GPx4 in mounting an antioxidant response. This concept is currently under investigation. Polymorphic variants of GSTP will also potentially influence S-glutathionylation of other client proteins' clusters [27] . Moreover, previous studies have suggested that GSTP1 polymorphisms are associated with cancer risk with frequencies of 0.65 (GSTP1-1A), 0.262 (GSTP1-1B), and 0.068 (GSTP1-1C) in Caucasian populations [22, 30] . Such differences will be of importance in the analysis of epidemiological data studying differences in population sensitivities to oxidant-stress-involving procedures.
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